Denver Investment Advisors’s Edwards Lifesciences EW Stock Holding History

Denver Investment Advisors’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-128,832	Closed	-$3.39M	–	483
2015 Q4	$3.39M	Sell	128,832 -53,610	-29%	-$1.39M	0.15%	162
2015 Q3	$4.32M	Buy	182,442 +4,260	+2%	+$103K	0.19%	139
2015 Q2	$4.23M	Sell	178,182 -178,050	-50%	-$4.02M	0.16%	146
2015 Q1	$8.46M	Sell	356,232 -4,080	-1%	-$91.5K	0.28%	105
2014 Q4	$7.65M	Sell	360,312 -204,120	-36%	-$4.1M	0.25%	115
2014 Q3	$9.61M	Sell	564,432 -22,014	-4%	-$348K	0.31%	90
2014 Q2	$8.39M	Buy	586,446 +169,836	+41%	+$2.3M	0.26%	109
2014 Q1	$5.15M	Buy	416,610 +73,170	+21%	+$844K	0.15%	180
2013 Q4	$3.76M	Buy	+343,440	New	+$3.87M	0.11%	225

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Denver Investment Advisors's EW Position: Q1 2016 in Review

Denver Investment Advisors sold out of Edwards Lifesciences (EW) in Q1 2016, closing a stake of 128,832 shares — an estimated $3.39M sold.

Denver Investment Advisors first reported a position in EW in Q4 2013 and held it in 9 quarters. The position peaked at $9.61M in Q3 2014. 659 funds tracked by Wall St. Rank hold EW as of Q1 2016.

Denver Investment Advisors reported no remaining Edwards Lifesciences position as of Q1 2016 after selling out during the quarter.
Denver Investment Advisors sold 128,832 Edwards Lifesciences shares in Q1 2016, an estimated $3.39M.
Denver Investment Advisors first reported a position in Edwards Lifesciences in Q4 2013 and held it in 9 quarters.
Denver Investment Advisors's Edwards Lifesciences position peaked at $9.61M in Q3 2014.
659 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2016.

Based on Denver Investment Advisors's 13F filing for Q1 2016, filed 12 May 2016.